Cargando…

Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity

Metaplastic breast carcinoma (MBC) is rare and has a poor prognosis. Here we describe genetic analysis of a 41-yr-old female patient with MBC and neurofibromatosis type I (NF1). She initially presented with pT3N1a, grade 3 MBC, but lung metastases were discovered subsequently. To identify the molecu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suarez-Kelly, Lorena P., Akagi, Keiko, Reeser, Julie W., Samorodnitsky, Eric, Reeder, Matthew, Smith, Amy, Roychowdhury, Sameek, Symer, David E., Carson, William E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory Press 2018
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880258/ https://www.ncbi.nlm.nih.gov/pubmed/29449315 http://dx.doi.org/10.1101/mcs.a002352

Ejemplares similares

Evaluation of Hybridization Capture Versus Amplicon‐Based Methods for Whole‐Exome Sequencing
por: Samorodnitsky, Eric, et al.
Publicado: (2015)

Metaplastic Breast Cancer in a Patient with Neurofibromatosis
por: Chaudhry, Umar Shafique, et al.
Publicado: (2015)

Metaplastic Carcinoma of Breast and Neurofibromatosis 1: A Rare Association
por: Vellaisamy, Gnanapriya, et al.
Publicado: (2017)

Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS
por: Kautto, Esko A., et al.
Publicado: (2016)

Oral Metastasis of Metaplastic Breast Carcinoma in a Patient with Neurofibromatosis 1
por: Vivas, Ana Paula Molina, et al.
Publicado: (2014)

Genomic characterization of metastatic ultra-hypermutated interdigitating dendritic cell sarcoma through rapid research autopsy
por: Chen, Hui-Zi, et al.
Publicado: (2019)

Dissecting Loss of Heterozygosity (LOH) in Neurofibromatosis Type 1-Associated Neurofibromas: Importance of Copy Neutral LOH
por: Garcia-Linares, Carles, et al.
Publicado: (2011)

Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance
por: Krook, Melanie A., et al.
Publicado: (2020)

Frequent somatic gene conversion as a mechanism for loss of heterozygosity in tumor suppressor genes
por: Takahashi, Kazuki K., et al.
Publicado: (2022)

Loss of heterozygosity: what is it good for?
por: Ryland, Georgina L., et al.
Publicado: (2015)

Somatic mosaicism for copy-neutral loss of heterozygosity and DNA copy number variations in the human genome
por: Žilina, Olga, et al.
Publicado: (2015)

Single-nucleus DNA sequencing reveals hidden somatic loss-of-heterozygosity in Cerebral Cavernous Malformations
por: Ressler, Andrew K., et al.
Publicado: (2023)

Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy
por: Krook, Melanie A., et al.
Publicado: (2019)

Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy
por: Chen, Hui-Zi, et al.
Publicado: (2021)

A new method to detect loss of heterozygosity using cohort heterozygosity comparisons
por: Green, Michael R, et al.
Publicado: (2010)

Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer
por: Ciani, Yari, et al.
Publicado: (2022)

Loss of Heterozygosity and Its Importance in Evolution
por: Smukowski Heil, Caiti
Publicado: (2023)

Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature
por: Suarez-Kelly, Lorena P., et al.
Publicado: (2019)

Loss of heterozygosity of TRIM3 in malignant gliomas
por: Boulay, Jean-Louis, et al.
Publicado: (2009)

Analysis of Loss of Heterozygosity in Korean Patients with Keratoacanthoma
por: Ha, Tae-Won, et al.
Publicado: (2005)

Loss of Heterozygosity Drives Adaptation in Hybrid Yeast
por: Smukowski Heil, Caiti S., et al.
Publicado: (2017)

Targeting tumor vulnerabilities associated with loss of heterozygosity
por: Rendo, Veronica, et al.
Publicado: (2020)

Fitness benefits of loss of heterozygosity in Saccharomyces hybrids
por: Lancaster, Samuel M., et al.
Publicado: (2019)

Targeting loss of heterozygosity for cancer-specific immunotherapy
por: Hwang, Michael S., et al.
Publicado: (2021)

Polyploidy as an Adaptation against Loss of Heterozygosity in Cancer
por: Archetti, Marco
Publicado: (2022)

Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma
por: Pastorino, Lorenza, et al.
Publicado: (2022)

Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors
por: Blish, Kimberly R, et al.
Publicado: (2010)

An Update on the Molecular Pathology of Metaplastic Breast Cancer
por: McCart Reed, Amy E, et al.
Publicado: (2021)

Loss of heterozygosity on the long arm of chromosome 11 in colorectal tumours.
por: Gustafson, C. E., et al.
Publicado: (1994)

Dynamic contrast-enhanced MRI and sequential CT findings of metaplastic breast carcinoma in neurofibromatosis type 1: A case report
por: Ando, Saya, et al.
Publicado: (2023)

Loss of heterozygosity at 7p in Wilms' tumour development
por: Powlesland, R M, et al.
Publicado: (2000)

Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan
por: Sheu, J-C, et al.
Publicado: (1999)

Loss of constitutional heterozygosity on chromosomes 5 and 17 in cholangiocarcinoma.
por: Ding, S. F., et al.
Publicado: (1993)

Loss of heterozygosity on chromosomes 1 and 11 in carcinoma of the pancreas.
por: Ding, S. F., et al.
Publicado: (1992)

Loss of heterozygosity of the oestrogen receptor gene in breast cancer.
por: Iwase, H., et al.
Publicado: (1995)

Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour.
por: Grundy, R. G., et al.
Publicado: (1998)

Genomic loss of heterozygosity and survival in the REAL3 trial
por: Smyth, Elizabeth C., et al.
Publicado: (2018)

Clinical Implications of Genomic Loss of Heterozygosity in Endometrial Carcinoma
por: Bustamante, Bethany, et al.
Publicado: (2021)

Value of the loss of heterozygosity to BRCA1 variant classification
por: Santana dos Santos, Elizabeth, et al.
Publicado: (2022)

Molecular Dissection of Somatic Skeletal Disease in Neurofibromatosis Type 1
por: Paria, Nandina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_egd038bv3db0m6ag0h124qmhvl